Investors in pharma mutual fund schemes are getting impatient, say mutual fund advisors. Disappointed by the bad show of the category in the past one year, several investors calling their mutual fund advisors to check whether they should get out of these schemes. The pharma fund category has returned -3.13 per cent in the last one year.
“Investors have been waiting for the pharma funds to perform for a year now. The category did see some positive changes, but the impact was momentary